To prepare a Eurostar application for the SECURE research project; development of a novel ß-lactamase inhibitor

Antimicrobial resistance (AMR) is an emerging and devastating global health problem caused directly by use and over-use of antibiotics. AMR jeopardizes our ability to perform many life-saving procedures such as surgery, cancer treatment, transplantations, etc. SECURE addresses this global need by developing novel technology securing antibiotic sensitivity in life-threatening, potentially multidrug resistant bacterial infections. SECURE is in the drug discovery phase of development and we will apply for Eurostars to fund a preclinical program and first-in-human study. The first phase of the PES project will be to define the research program. Then we will identify research partners that can deliver on these activities and finally coordinate and write the Eurostar application with inputs from all partners in the consortium.